Best Lung Cancer Treatment Hospital in Nagpur

Fuda Cancer Hospital – Lung Cancer Support for Nagpur Patients

If you are in Nagpur and looking for expert lung cancer treatment, Fuda Cancer Hospital offers advanced options. Fuda’s main hospital is located in Guangzhou, China. In India, Fuda partners with Rekosh Health Care to support patients. While there is no full Fuda hospital in Nagpur, you can get online consultation, personalised treatment plans, second opinions and follow-up care. For in-person visits and follow-up treatment, Fuda operates two Consultation Centres in India — Mumbai and Noida. These centres also provide palliative care and help coordinate your ongoing treatment plan, giving Nagpur patients international expertise with local support.

Advanced Lung Cancer Care for Patients Across Nagpur, Vidarbha & Central India

A diagnosis of lung cancer can be life-changing. Along with concerns about health, patients and families often have many questions. What type of lung cancer is it? Has it spread? Is surgery the best option? Would targeted therapy or immunotherapy be more appropriate? Should you seek a second opinion before starting treatment?

For patients in Nagpur, these questions have become increasingly important as lung cancer continues to affect people across Maharashtra and Central India. While smoking remains one of the major causes, doctors are also seeing lung cancer in many people who have never smoked. Environmental pollution, occupational exposure, previous lung diseases, and genetic factors are now recognised as important contributors to the disease. A study from Government Medical College and Hospital (GMCH), Nagpur reported that more than half of the lung cancer patients evaluated were non-smokers, highlighting the growing impact of environmental risk factors.

Nagpur serves as a major healthcare hub for the Vidarbha region. Patients frequently travel here from Wardha, Chandrapur, Bhandara, Gondia, Amravati, Yavatmal, Akola, Washim, Gadchiroli, and nearby districts for specialist medical care. Because of its central location and excellent transport connectivity, Nagpur also receives patients from neighbouring parts of Madhya Pradesh, Chhattisgarh, and Telangana.

One of the greatest challenges with lung cancer is that it often develops silently. During the early stages, symptoms may be mild or completely absent. Many patients ignore a persistent cough or shortness of breath, assuming that the symptoms are related to smoking, seasonal infections, pollution, or ageing. Unfortunately, this delay may allow the disease to progress before treatment begins.

Early diagnosis has transformed lung cancer care. Advances in imaging, pathology, molecular testing, targeted therapy, immunotherapy, minimally invasive procedures, and multidisciplinary cancer care now allow doctors to create highly personalised treatment plans based on each patient’s diagnosis.

Fuda Cancer Hospital, with its internationally recognised cancer centre in Guangzhou, China, works in collaboration with Rekosh Health Care in India to help patients access expert consultations, multidisciplinary treatment planning, second opinions, and coordinated follow-up care. Patients from Nagpur can begin with an online consultation, upload CT scans, PET-CT images, biopsy reports, pathology findings, and previous treatment records for expert review. When in-person evaluation is needed, consultation centres in Mumbai and Noida provide additional support.

Modern lung cancer treatment is no longer limited to surgery or chemotherapy. Depending on the diagnosis, treatment may include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, Cryotherapy, NanoKnife Irreversible Electroporation (IRE), or a combination of these approaches. Each treatment plan is tailored according to the type of lung cancer, stage of disease, molecular profile, lung function, and the patient’s overall health.

This guide has been created specifically for patients from Nagpur and the Vidarbha region. It explains lung cancer in simple language, discusses symptoms, diagnosis, treatment options, recovery, and supportive care, while helping patients and families make informed decisions throughout their treatment journey.

Why Lung Cancer Is Becoming a Growing Health Concern in Nagpur

Lung cancer is increasingly recognised as a significant health concern across Vidarbha. While tobacco smoking remains the most important risk factor, doctors are diagnosing more patients who have never smoked. Recent clinical observations from Nagpur have drawn attention to the role of air pollution, environmental toxins, and occupational exposure in the development of lung cancer.

Smoking and Tobacco Use

Smoking cigarettes, beedis, cigars, and other tobacco products remains the leading cause of lung cancer. Long-term exposure to tobacco smoke damages lung cells, increasing the likelihood of cancer over time.

Air Pollution

Rapid urbanisation, traffic emissions, industrial activity, and environmental pollution contribute to declining air quality in many cities, including Nagpur. Continuous exposure to airborne pollutants may increase the risk of chronic respiratory disease and lung cancer, particularly in susceptible individuals.

Occupational Exposure

Workers in mining, power generation, construction, manufacturing, engineering, transport, and chemical industries may be exposed to asbestos, silica dust, diesel exhaust, heavy metals, and industrial fumes. Long-term occupational exposure without adequate protection may increase lung cancer risk.

Previous Lung Diseases

People with chronic respiratory illnesses such as Chronic Obstructive Pulmonary Disease (COPD), pulmonary fibrosis, bronchiectasis, or a previous history of tuberculosis should seek medical evaluation if respiratory symptoms persist or worsen.

Family History and Genetics

Some patients develop lung cancer despite never smoking. Family history and specific genetic mutations may contribute to the development of the disease and also influence treatment decisions, particularly regarding targeted therapy.

Increasing Age

Although lung cancer can occur at any age, the risk generally increases after the age of 50 because harmful exposures accumulate over time. Nevertheless, younger adults may also develop lung cancer, particularly when genetic or environmental factors are involved.

Understanding the Lungs

The lungs are responsible for supplying oxygen to the bloodstream and removing carbon dioxide from the body. Every breath supports the function of the heart, brain, muscles, and every other organ.

The right lung contains three lobes, while the left lung contains two lobes to accommodate the heart. Air passes through the windpipe into the bronchi and finally reaches millions of tiny air sacs called alveoli, where oxygen enters the bloodstream.

Because the lungs remain in constant contact with the external environment, they are exposed every day to cigarette smoke, pollution, dust, industrial chemicals, allergens, and infectious organisms. Repeated exposure to harmful substances may damage the DNA of normal lung cells. If this damage is not repaired, abnormal cells can multiply uncontrollably and eventually form a tumour.

During the early stages, lung cancer may remain confined to the lungs. If untreated, it may spread through the lymphatic system or bloodstream to nearby lymph nodes and distant organs such as the brain, liver, bones, or adrenal glands. This is why early diagnosis and timely treatment remain essential for improving outcomes.

What Is Lung Cancer?

Lung cancer is a disease in which abnormal cells within the lungs begin to grow uncontrollably, eventually forming a tumour. Unlike healthy cells that grow, divide, and die in a controlled manner, cancer cells continue multiplying without regulation. As these abnormal cells increase, they can invade surrounding lung tissue, block the airways, spread to nearby lymph nodes, and eventually travel to distant organs through the bloodstream or lymphatic system.

The lungs are among the most important organs in the body because they continuously supply oxygen to every tissue while removing carbon dioxide. Since the lungs remain in constant contact with the external environment, they are exposed daily to cigarette smoke, industrial pollutants, vehicle emissions, dust particles, allergens, infectious organisms, and various harmful chemicals. Long-term exposure to these substances may damage the DNA of normal lung cells. When the body’s natural repair mechanisms fail to correct this damage, abnormal cells may begin multiplying uncontrollably, leading to the development of lung cancer.

One of the biggest challenges with lung cancer is that it often develops silently. Small tumours rarely produce obvious symptoms during the early stages. Many patients seek medical attention only after the disease has progressed and symptoms become more noticeable. This is why awareness, early diagnosis, and timely treatment are extremely important.

Fortunately, advances in medical science have transformed the management of lung cancer. Modern imaging techniques, molecular testing, targeted therapy, immunotherapy, minimally invasive procedures, and multidisciplinary cancer care now allow treatment to be personalised according to each patient’s diagnosis and overall health.

Types of Lung Cancer

Lung cancer is not a single disease. It includes several different types that behave differently and respond to different treatments. Identifying the exact type of lung cancer is one of the most important steps before treatment begins.

Modern treatment planning also includes molecular profiling to identify genetic changes that may respond to targeted medicines.

Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer (NSCLC) accounts for approximately 85% of all lung cancer cases.

Compared with Small Cell Lung Cancer, NSCLC usually grows more slowly and often offers greater opportunities for surgery or other curative treatments when diagnosed early.

NSCLC is divided into three main subtypes.

Adenocarcinoma

Adenocarcinoma is the most commonly diagnosed type of lung cancer worldwide. It usually develops in the outer portions of the lungs and is increasingly seen in people who have never smoked.

Many patients experience few symptoms during the early stages, making routine evaluation of persistent respiratory complaints particularly important.

Common symptoms include:

• Persistent cough

• Breathlessness

• Mild chest discomfort

• Fatigue

• Loss of appetite

• Unexplained weight loss

Because adenocarcinoma frequently contains specific genetic mutations, doctors often recommend molecular testing for:

• EGFR

• ALK

• ROS1

• KRAS

• BRAF

• MET

• RET

These genetic findings help specialists determine whether targeted therapy may be beneficial.

Squamous Cell Carcinoma

Squamous Cell Carcinoma develops in the larger airways of the lungs and has a strong association with long-term tobacco smoking.

Because these tumours often arise near the main bronchi, symptoms may appear earlier than with some other lung cancers.

Patients commonly experience:

• Persistent cough

• Blood in sputum

• Wheezing

• Chest pain

• Recurrent lung infections

• Difficulty breathing

Treatment depends on the stage of disease and may include surgery, chemotherapy, radiation therapy, immunotherapy, or combinations of these treatments.

Large Cell Carcinoma

Large Cell Carcinoma is a less common subtype of NSCLC.

It can develop in almost any part of the lung and may grow more rapidly than adenocarcinoma or squamous cell carcinoma.

Treatment recommendations depend on:

• Tumour size

• Cancer stage

• Molecular profile

• Patient’s age

• Overall health

• Lung function

Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer accounts for approximately 10–15% of lung cancer cases.

Unlike NSCLC, SCLC usually grows rapidly and tends to spread early to other organs such as:

• Brain

• Liver

• Bones

• Adrenal glands

• Lymph nodes

Although surgery is less commonly performed, chemotherapy, radiation therapy, and immunotherapy often play important roles in treatment.

Early diagnosis remains essential because prompt treatment may improve disease control and quality of life.

Metastatic Lung Cancer

Metastatic lung cancer refers to lung cancer that has spread beyond the lungs.

Cancer cells may travel through the bloodstream or lymphatic system to other parts of the body.

Common sites of spread include:

• Brain

• Liver

• Bones

• Adrenal glands

• Distant lymph nodes

Although metastatic disease is more complex to treat, advances in personalised medicine, targeted therapy, immunotherapy, and supportive care have improved outcomes for many patients.

Early Symptoms of Lung Cancer

Lung cancer symptoms vary from one patient to another.

Some people experience only mild symptoms during the early stages, while others remain symptom-free until the disease has progressed.

Many early symptoms resemble common respiratory illnesses such as bronchitis, allergies, or seasonal infections, causing patients to delay seeking medical advice.

Anyone experiencing persistent symptoms for more than two to three weeks should consult a healthcare professional.

Persistent Cough

A cough lasting several weeks or gradually becoming worse is one of the earliest warning signs of lung cancer.

Smokers often assume that a chronic cough is normal and ignore changes in its severity.

Any persistent or changing cough should be medically evaluated.

Coughing Up Blood

Even small amounts of blood in sputum should never be ignored.

Although respiratory infections may occasionally produce blood-stained sputum, lung cancer is one of the important conditions that doctors must rule out.

Immediate medical evaluation is recommended.

Chest Pain

Persistent chest pain may occur when a tumour affects the lining of the lungs or nearby tissues.

Patients often describe pain that:

• Worsens during coughing

• Increases while taking deep breaths

• Persists despite routine pain medication

• Interferes with daily activities

Shortness of Breath

Breathlessness develops when a tumour blocks part of the airway, reduces lung capacity, or causes fluid accumulation around the lungs.

Initially, patients may notice difficulty climbing stairs or walking long distances before symptoms gradually worsen.

Wheezing

A new wheezing sound during breathing should not be ignored, especially in individuals without asthma.

A tumour narrowing the airway may partially obstruct airflow and produce wheezing.

Hoarseness of Voice

Lung tumours located near nerves controlling the vocal cords may cause:

• Persistent hoarseness

• Voice changes

• Difficulty speaking loudly

Hoarseness lasting longer than three weeks requires medical assessment.

Repeated Chest Infections

Repeated episodes of pneumonia or bronchitis affecting the same part of the lung may indicate an underlying tumour blocking the airway.

Prompt investigation is recommended.

Fatigue

Cancer-related fatigue is different from ordinary tiredness.

Patients often describe:

• Persistent exhaustion

• Lack of energy

• Reduced ability to perform routine activities

• Poor recovery despite adequate sleep

Unexplained Weight Loss

Unexpected weight loss without dieting or increased physical activity is an important warning sign.

Patients may also notice:

• Poor appetite

• Muscle loss

• General weakness

• Reduced physical stamina

Bone Pain

If lung cancer spreads to the bones, patients may develop persistent pain involving:

• Spine

• Ribs

• Shoulder

• Pelvis

• Hip

Persistent bone pain should always be medically evaluated.

Headaches and Neurological Symptoms

When lung cancer spreads to the brain, symptoms may include:

• Persistent headaches

• Dizziness

• Weakness

• Vision problems

• Difficulty walking

• Seizures

These symptoms require urgent medical attention.

Causes and Risk Factors

Lung cancer develops because of a combination of lifestyle, environmental, occupational, and genetic factors.

Smoking remains the leading cause worldwide, but increasing numbers of patients diagnosed today have never smoked.

Major risk factors include:

• Cigarette smoking

• Beedi smoking

• Tobacco use

• Second-hand smoke

• Air pollution

• Industrial emissions

• Mining and occupational dust exposure

• Asbestos

• Silica dust

• Diesel exhaust

• Previous tuberculosis

• COPD

• Pulmonary fibrosis

• Family history of lung cancer

• Increasing age

• Genetic mutations

For people living in Nagpur and the Vidarbha region, environmental pollution, industrial exposure, mining activities, and occupational hazards may contribute to respiratory health risks alongside tobacco use.

Who Is at Higher Risk?

The following individuals should pay particular attention to persistent respiratory symptoms:

• Current smokers

• Former smokers

• Adults above 50 years of age

• Individuals exposed to second-hand smoke

• Workers in mining, power plants, construction, engineering, manufacturing, and transport industries

• People with COPD or previous tuberculosis

• Individuals with a family history of lung cancer

• Residents exposed to prolonged air pollution or industrial dust

Being at higher risk does not necessarily mean a person will develop lung cancer. However, recognising these factors encourages earlier medical evaluation, timely diagnosis, and access to appropriate treatment when needed.

When Should You Consult a Lung Cancer Specialist?

Many people ignore persistent respiratory symptoms because they assume they are caused by seasonal infections, allergies, smoking, ageing, or pollution. Unfortunately, delaying medical evaluation may allow lung cancer to progress before it is diagnosed.

Early diagnosis remains one of the most important factors influencing successful treatment. Patients diagnosed during the early stages generally have more treatment options and better long-term outcomes than those diagnosed after the disease has spread.

If you live in Nagpur, Wardha, Chandrapur, Amravati, Akola, Yavatmal, Bhandara, Gondia, Gadchiroli, Washim, or nearby districts, you should consult a doctor if you experience:

• A cough lasting more than three weeks

• Coughing up blood

• Persistent chest pain

• Increasing shortness of breath

• Hoarseness of voice

• Wheezing without asthma

• Recurrent pneumonia or chest infections

• Unexplained weight loss

• Persistent fatigue

• Bone pain or headaches associated with respiratory symptoms

Seeking medical advice does not necessarily mean you have lung cancer. However, timely evaluation helps identify the underlying cause and allows treatment to begin as early as possible if cancer is diagnosed.

How Is Lung Cancer Diagnosed?

Modern lung cancer diagnosis involves much more than identifying a shadow on a chest X-ray. Specialists use advanced imaging, tissue biopsy, pathology, molecular testing, and multidisciplinary assessment to accurately diagnose the disease and recommend the most appropriate treatment.

Patients from Nagpur can complete many investigations locally before seeking an expert review or second opinion.

Medical History and Physical Examination

Every evaluation begins with a detailed consultation.

Your doctor may ask about:

• Duration and progression of symptoms

• Smoking or tobacco history

• Occupational exposure

• Previous tuberculosis or chronic lung disease

• Family history of cancer

• Weight loss

• Appetite changes

• Current medications

• Previous cancer treatment

• Other medical illnesses

A physical examination may identify enlarged lymph nodes, abnormal breathing sounds, reduced oxygen levels, or other findings requiring further investigation.

Chest X-ray

A chest X-ray is usually the first imaging test performed when lung cancer is suspected.

Although it cannot diagnose every lung tumour, it helps identify:

• Lung masses

• Persistent pneumonia

• Lung collapse

• Fluid around the lungs

• Enlarged lymph nodes

If an abnormality is detected, more detailed imaging is generally recommended.

CT Scan (Computed Tomography)

A CT scan provides detailed cross-sectional images of the lungs and surrounding structures.

Compared with a standard X-ray, CT scanning offers much greater detail regarding:

• Exact tumour location

• Tumour size

• Airway involvement

• Blood vessel involvement

• Enlarged lymph nodes

• Spread within the chest

CT imaging also helps specialists decide whether surgery, biopsy, or additional investigations are appropriate.

PET-CT Scan

PET-CT combines Positron Emission Tomography (PET) with Computed Tomography (CT).

Before the scan, a small amount of radioactive glucose is injected into the bloodstream. Since cancer cells consume more glucose than normal cells, they appear as areas of increased activity during imaging.

PET-CT helps determine:

• Whether cancer has spread beyond the lungs

• Lymph node involvement

• Suitability for surgery

• Response to treatment

• Possible recurrence after treatment

PET-CT has become one of the most valuable investigations in lung cancer staging.

MRI Scan

MRI is generally recommended when doctors suspect that lung cancer has spread to the brain, spine, or other soft tissues.

MRI provides excellent visualisation of the nervous system and is particularly useful for patients experiencing:

• Persistent headaches

• Dizziness

• Weakness

• Vision problems

• Difficulty walking

• Seizures

Bronchoscopy

Bronchoscopy is a minimally invasive procedure that allows specialists to examine the inside of the airways using a flexible camera.

During bronchoscopy doctors can:

• Inspect the airways

• Identify abnormal growths

• Obtain tissue samples

• Assess airway narrowing

• Remove secretions if necessary

The procedure is usually performed under sedation, and most patients return home on the same day.

Endobronchial Ultrasound (EBUS)

Endobronchial Ultrasound combines bronchoscopy with ultrasound imaging.

This advanced technique enables doctors to examine lymph nodes deep inside the chest and obtain biopsy samples without the need for major surgery.

EBUS plays an important role in accurate staging and treatment planning.

CT-Guided Needle Biopsy

When a tumour is located near the outer part of the lung, a CT-guided biopsy may be recommended.

Using CT imaging for guidance, a specialised needle is inserted through the chest wall to obtain a small tissue sample.

The sample is then examined under a microscope by a pathologist.

Histopathology

A biopsy remains the gold standard for confirming lung cancer.

The pathology report provides detailed information regarding:

• Type of lung cancer

• Tumour grade

• Cell characteristics

• Additional microscopic features

Without biopsy confirmation, a definite diagnosis of lung cancer generally cannot be established.

Molecular Testing

One of the greatest advances in modern oncology is molecular profiling.

Rather than simply identifying cancer under the microscope, specialists analyse genetic changes within tumour cells.

Common biomarkers include:

• EGFR

• ALK

• ROS1

• KRAS

• BRAF

• MET

• RET

• NTRK

• PD-L1

Patients with these biomarkers may benefit from targeted therapy or immunotherapy.

Molecular testing has become an essential part of personalised treatment planning for many patients with Non-Small Cell Lung Cancer.

Liquid Biopsy

Liquid biopsy is an advanced blood test that detects tumour DNA circulating within the bloodstream.

It may be useful:

• When tissue biopsy is difficult

• To identify additional genetic mutations

• To monitor treatment response

• To evaluate suspected recurrence

Although not suitable for every patient, liquid biopsy has become an increasingly valuable tool in precision oncology.

Understanding Lung Cancer Staging

After confirming the diagnosis, specialists determine how far the cancer has spread.

This process is known as staging.

Accurate staging helps doctors recommend the most appropriate treatment strategy.

Stage 0

Cancer cells remain confined to the lining of the airways without invading deeper tissues.

Treatment at this stage often offers excellent long-term outcomes.

Stage I

The tumour remains confined to the lung without lymph node involvement.

Many patients diagnosed at this stage are suitable candidates for surgery or other treatments with curative intent.

Stage II

The tumour may be larger or involve nearby lymph nodes.

Treatment often includes surgery followed by chemotherapy and, in selected patients, radiation therapy.

Stage III

Cancer has spread to lymph nodes within the chest or nearby structures.

Treatment usually combines:

• Chemotherapy

• Radiation therapy

• Immunotherapy

• Surgery in carefully selected patients

Management typically involves discussion by a multidisciplinary oncology team.

Stage IV

Stage IV lung cancer indicates that the disease has spread beyond the lungs to distant organs such as the brain, liver, bones, or adrenal glands.

Although Stage IV disease is generally not considered curable, advances in targeted therapy, immunotherapy, chemotherapy, and supportive care have significantly improved survival and quality of life for many patients.

Personalised Treatment Planning

No two lung cancer patients are exactly alike.

Every treatment recommendation is developed after carefully considering:

• Type of lung cancer

• Stage of disease

• Molecular profile

• Patient’s age

• General health

• Lung function

• Previous treatments

• Individual treatment goals

Patients from Nagpur seeking a second opinion through Fuda Cancer Hospital can have their CT scans, PET-CT images, biopsy reports, pathology findings, and molecular testing reviewed by an experienced multidisciplinary oncology team. This collaborative approach helps ensure that every patient receives an evidence-informed, personalised treatment plan tailored to their diagnosis and overall clinical condition before treatment begins.

Advanced Treatment Options for Lung Cancer

Over the past two decades, lung cancer treatment has advanced remarkably. Today, treatment is highly personalised and based on several important factors, including the type of lung cancer, stage of the disease, molecular profile, overall health, lung function, age, and the patient’s treatment goals.

For patients from Nagpur, Wardha, Chandrapur, Amravati, Akola, Yavatmal, Bhandara, Gondia, Gadchiroli, and across the Vidarbha region, modern oncology offers multiple treatment options that may be used individually or in combination. Every case is reviewed by a multidisciplinary team to ensure the most appropriate treatment plan.

Surgery for Lung Cancer

Surgery remains one of the most effective treatments for patients diagnosed with early-stage Non-Small Cell Lung Cancer (NSCLC). The aim is to completely remove the tumour while preserving as much healthy lung tissue as possible.

Before recommending surgery, doctors carefully assess:

• Stage of the disease

• Tumour size and location

• Lung function

• Heart health

• General fitness for surgery

• Other existing medical conditions

Types of Surgery

Wedge Resection

A wedge resection removes the tumour together with a small margin of healthy lung tissue. It may be considered for very small tumours or for patients with reduced lung function who may not tolerate larger surgical procedures.

Segmentectomy

During a segmentectomy, only one anatomical segment of the lung is removed rather than an entire lobe. This helps preserve healthy lung tissue while providing effective treatment for carefully selected patients.

Lobectomy

A lobectomy involves removal of one complete lobe of the lung. It remains the standard surgical treatment for many early-stage lung cancers and provides excellent long-term cancer control when the disease is confined to a single lobe.

Pneumonectomy

In some situations where the tumour involves major airways or occupies a large portion of the lung, removal of the entire lung may be necessary. Although it is a major operation, many patients recover well with appropriate rehabilitation and long-term follow-up.

Chemotherapy

Chemotherapy uses specialised anti-cancer medicines to destroy rapidly growing cancer cells throughout the body.

It may be recommended:

• Before surgery to shrink the tumour (Neoadjuvant Chemotherapy)

• After surgery to reduce the risk of recurrence (Adjuvant Chemotherapy)

• Together with radiation therapy

• For advanced or metastatic lung cancer

• To control symptoms and improve quality of life

Treatment is generally administered in cycles, allowing the body time to recover between sessions.

Possible Side Effects

Modern supportive medications have greatly improved the management of chemotherapy-related side effects.

Some patients may experience:

• Fatigue

• Nausea and vomiting

• Temporary hair loss

• Reduced immunity

• Mouth ulcers

• Loss of appetite

• Tingling or numbness in the hands and feet

Not every patient experiences these side effects, and many can be managed effectively with appropriate medical support.

Radiation Therapy

Radiation therapy uses precisely targeted high-energy radiation to destroy cancer cells while minimising damage to surrounding healthy tissues.

It may be recommended:

• As the primary treatment when surgery is not suitable

• Before surgery to reduce tumour size

• After surgery to lower the risk of recurrence

• Combined with chemotherapy

• To relieve symptoms caused by advanced disease

Modern Radiation Techniques

Intensity-Modulated Radiation Therapy (IMRT)

IMRT delivers radiation from multiple angles while adjusting the intensity of each beam. This enables specialists to treat the tumour accurately while protecting nearby organs such as the heart, spinal cord, and healthy lung tissue.

Stereotactic Body Radiation Therapy (SBRT)

SBRT delivers very high doses of radiation with exceptional precision over a small number of treatment sessions. It may be appropriate for selected patients with small, localised lung tumours who are not candidates for surgery.

Targeted Therapy

Targeted therapy has revolutionised the treatment of many patients with Non-Small Cell Lung Cancer.

Unlike chemotherapy, targeted therapy specifically attacks cancer cells carrying particular genetic mutations while causing less damage to many normal cells.

Before treatment, molecular testing helps identify biomarkers such as:

• EGFR

• ALK

• ROS1

• KRAS

• BRAF

• MET

• RET

• NTRK

Patients with these mutations may benefit from medicines specifically designed to block abnormal cancer cell growth.

Advantages of Targeted Therapy

• Precision-based treatment

• Often available as oral medication

• Different side-effect profile compared with chemotherapy

• Improved disease control in selected patients

• Personalised treatment approach

Immunotherapy

Immunotherapy is one of the most significant advances in modern cancer treatment.

Rather than directly attacking cancer cells, immunotherapy helps the body’s immune system recognise and destroy them.

Cancer cells often evade immune surveillance by producing proteins that suppress immune responses. Immunotherapy blocks these protective mechanisms, enabling immune cells to attack cancer more effectively.

Doctors may perform PD-L1 testing or other biomarker assessments before recommending immunotherapy.

It may be used:

• Alone

• Combined with chemotherapy

• Following chemotherapy and radiation therapy

• For advanced or metastatic lung cancer

• In selected patients after surgery

Cryotherapy (Cryosurgery)

Cryotherapy, also called Cryoablation or Cryosurgery, is a minimally invasive treatment that destroys selected tumours using extremely low temperatures.

Using advanced imaging guidance, a specialised probe is inserted into or near the tumour. Controlled freezing and thawing cycles damage cancer cells while preserving surrounding healthy tissue.

Potential benefits include:

• Minimally invasive treatment

• Reduced blood loss

• Smaller incision

• Faster recovery

• Preservation of surrounding lung tissue in selected patients

Suitability depends on tumour size, location, and overall clinical assessment.

NanoKnife Irreversible Electroporation (IRE)

NanoKnife IRE is an advanced treatment that uses carefully controlled electrical pulses instead of heat or freezing to destroy selected tumours.

These electrical pulses create microscopic openings in cancer cell membranes, leading to cell death while helping preserve nearby blood vessels, nerves, and other important structures.

NanoKnife IRE may be considered for selected patients whose tumours are located close to critical anatomical structures where conventional surgery or thermal ablation may be challenging.

Recovery and Rehabilitation

Recovery after lung cancer treatment varies depending on the treatment received and the patient’s overall health.

Important aspects of recovery include:

• Pulmonary rehabilitation

• Breathing exercises

• Gradual return to physical activity

• Smoking cessation

• Nutritional support

• Regular follow-up imaging

• Symptom monitoring

• Emotional counselling when required

A structured rehabilitation programme helps many patients improve lung function, reduce fatigue, and regain confidence in everyday activities.

Nutrition During Lung Cancer Treatment

Good nutrition supports healing, maintains muscle strength, and enables the body to tolerate treatment more effectively.

General dietary recommendations include:

• Eat small, frequent meals throughout the day.

• Include protein-rich foods such as eggs, fish, lean meat, pulses, paneer, tofu, and dairy products.

• Consume a variety of fresh fruits and vegetables.

• Drink adequate water and maintain hydration.

• Limit processed foods, excessive sugar, and alcohol.

• Seek advice from a clinical dietitian if swallowing becomes difficult or appetite decreases significantly.

Why Nagpur Patients Choose Fuda Cancer Hospital

Patients from Nagpur and surrounding districts often seek expert guidance to better understand their diagnosis and explore advanced treatment options.

Through its collaboration with Rekosh Health Care in India, Fuda Cancer Hospital provides:

• Expert second-opinion services

• Multidisciplinary case discussions

• Personalised treatment planning

• Review of CT scans, PET-CT scans, and pathology reports

• Guidance on advanced treatment options

• Follow-up care coordination

• Consultation support through Mumbai and Noida centres

Treatment Journey for Patients from Nagpur

Step 1 – Book an Expert Consultation

Patients can begin with an online or in-person consultation to discuss their diagnosis, symptoms, and previous treatments.

Step 2 – Share Medical Reports

The medical team reviews:

• CT scans

• PET-CT scans

• MRI reports

• Bronchoscopy findings

• Biopsy reports

• Histopathology reports

• Molecular testing reports

• Previous treatment records

Step 3 – Multidisciplinary Review

Specialists assess the cancer type, stage, molecular profile, and overall health before preparing a personalised treatment recommendation.

Step 4 – Personalised Treatment Planning

Based on the evaluation, an individualised treatment plan may include:

• Surgery

• Chemotherapy

• Radiation Therapy

• Targeted Therapy

• Immunotherapy

• Cryotherapy

• NanoKnife IRE

• Palliative and supportive care

Step 5 – Long-Term Follow-up

Patients continue with regular follow-up appointments, imaging, pulmonary rehabilitation, nutritional counselling, and supportive care to monitor recovery and detect any recurrence at an early stage.

Lung Cancer Treatment Cost in Nagpur

The overall cost of treatment depends on the stage of disease, diagnostic investigations, hospital stay, medications, and the chosen treatment approach.

Actual treatment costs vary depending on the patient’s diagnosis, treatment plan, medications, and duration of care.

Prevention Tips

Although not every case of lung cancer can be prevented, the following measures may reduce the overall risk:

• Stop smoking and avoid all tobacco products.

• Avoid second-hand smoke.

• Reduce exposure to air pollution and occupational dust whenever possible.

• Use appropriate protective equipment in industrial workplaces.

• Maintain a healthy diet and regular physical activity.

• Seek medical evaluation for persistent respiratory symptoms.

• Attend regular health check-ups if you have significant risk factors.

Frequently Asked Questions

1. Can non-smokers develop lung cancer?

Yes. Lung cancer can occur in non-smokers due to genetic factors, air pollution, occupational exposure, passive smoking, or previous lung diseases.

2. What are the earliest symptoms of lung cancer?

Persistent cough, breathlessness, chest pain, coughing up blood, fatigue, hoarseness, repeated chest infections, and unexplained weight loss.

3. Is lung cancer curable?

Some early-stage lung cancers can be treated with curative intent. The outcome depends on the cancer type, stage, and response to treatment.

4. Is surgery necessary for every patient?

No. Treatment depends on the stage and type of lung cancer. Many patients receive chemotherapy, radiation therapy, targeted therapy, immunotherapy, or combinations of these treatments.

5. What is molecular testing?

Molecular testing identifies genetic mutations such as EGFR, ALK, ROS1, and others that help doctors determine whether targeted therapy is appropriate.

6. What is immunotherapy?

Immunotherapy helps the body’s immune system recognise and attack cancer cells and may be recommended for eligible patients.

7. What is Cryotherapy?

Cryotherapy is a minimally invasive procedure that destroys selected tumours using extremely low temperatures.

8. What is NanoKnife IRE?

NanoKnife IRE uses electrical pulses to destroy selected tumours while helping preserve nearby healthy blood vessels and nerves.

9. Can I seek a second opinion before treatment?

Yes. Many patients seek a second opinion to better understand their diagnosis and explore all available treatment options before starting therapy.

10. Can treatment planning begin after an online consultation?

Yes. Many patients begin by sharing their medical reports online, allowing specialists to review the case and recommend further investigations or treatment before an in-person visit if required.

Conclusion

Lung cancer is a complex disease, but advances in diagnosis, molecular testing, targeted therapy, immunotherapy, surgery, and minimally invasive treatments have significantly improved patient care. Early diagnosis and personalised treatment planning allow doctors to select the most appropriate therapy for each individual.

For patients in Nagpur and across the Vidarbha region, timely consultation and expert guidance can make a meaningful difference. Whether you have recently been diagnosed, are considering a second opinion, or wish to explore advanced treatment options, discussing your case with an experienced multidisciplinary oncology team can help you make informed decisions.

Schedule Your Consultation

If you or a loved one has been diagnosed with lung cancer, you can begin by requesting an expert consultation through Rekosh Health Care, the India partner supporting patient coordination with Fuda Cancer Hospital.

The team can assist with:

• Expert second opinions

• Medical report review

• Personalised treatment planning

• Guidance on advanced treatment options

• Coordination of consultations and follow-up care

Early consultation can help you better understand your diagnosis and explore the most appropriate treatment options for your individual condition.